CVE-2023-38952

Description

Insecure access control in ZKTeco BioTime through 9.0.1 allows authenticated attackers to escalate their privileges due to the fact that session ids are not validated for the type of user accessing the application by default. Privilege restrictions between non-admin and admin users are not enforced and any authenticated user can leverage admin functions without restriction by making direct requests to administrative endpoints.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.08%
Third-Party Advisory claroty.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://zkteco.com product
https://claroty.com/team82/disclosure-dashboard/cve-2023-38952 third party advisory
https://github.com/omair2084/biotime-rce-8.5.5/blob/main/biotime_enum.py
https://krashconsulting.com/fury-of-fingers-biotime-rce/
https://sploitus.com/exploit?id=PACKETSTORM:177859

Frequently Asked Questions

What is the severity of CVE-2023-38952?
CVE-2023-38952 has been scored as a high severity vulnerability.
How to fix CVE-2023-38952?
To fix CVE-2023-38952, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-38952 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-38952 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.